The Enterprise Value as of December 2025 (TTM) for BioCryst Pharmaceuticals, Inc. (BCRX) is 2.30B

According to BioCryst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.30B. This represents a change of 30.53% compared to the average of 1.76B of the last 4 quarters.

BioCryst Pharmaceuticals, Inc. (BCRX) Historical Enterprise Value (quarterly & annually)

How has BCRX Enterprise Value performed in the past?

The mean historical Enterprise Value of BioCryst Pharmaceuticals, Inc. over the last ten years is 1.35B. The current 2.30B Enterprise Value has changed 16.95% with respect to the historical average. Over the past ten years (40 quarters), BCRX's Enterprise Value was at its highest in in the March 2022 quarter at 3.22B. The Enterprise Value was at its lowest in in the September 2025 quarter at 0.

BioCryst Pharmaceuticals, Inc. (BCRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioCryst Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioCryst Pharmaceuticals, Inc. (BCRX) Average Enterprise Value

How has BCRX Enterprise Value performed in the past?

The current Enterprise Value of BioCryst Pharmaceuticals, Inc. (BCRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioCryst Pharmaceuticals, Inc. (BCRX) Enterprise Value vs. Peers

How is BCRX’s Enterprise Value compared to its peers?

BioCryst Pharmaceuticals, Inc.’s Enterprise Value is greater than Zymeworks Inc. (-43935349065.00), greater than Ardelyx, Inc. (1.58B), greater than Maze Therapeutics, Inc. (1.76B), greater than Pharvaris N.V. (1.34B), greater than Spyre Therapeutics, Inc. (1.96B), greater than Intellia Therapeutics, Inc. (925.20M), greater than Trevi Therapeutics, Inc. (1.67B), greater than Wave Life Sciences Ltd. (1.07B), greater than Stoke Therapeutics, Inc. (1.69B), greater than Upstream Bio, Inc. (1.46B),

Build a custom stock screener for BioCryst Pharmaceuticals, Inc. (BCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCryst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioCryst Pharmaceuticals, Inc. (BCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioCryst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.